Smoking tobacco reduces lung function. African Americans have both lower lung function and decreased metabolism of tobacco smoke compared to European Americans. African ancestry is also associated with lower pulmonary function in African Americans. We aimed to determine whether African ancestry modifies the association between smoking and lung function and its rate of decline in African Americans.
We evaluated a prospective ongoing cohort of 1,281 African Americans participating in the Health, Aging, and Body Composition (Health ABC) Study initiated in 1997. We also examined an ongoing prospective cohort initiated in 1985 of 1,223 African Americans in the Coronary Artery Disease in Young Adults (CARDIA) Study. Pulmonary function and tobacco smoking exposure were measured at baseline and repeatedly over the follow-up period. Individual genetic ancestry proportions were estimated using ancestry informative markers selected to distinguish European and West African ancestry. African Americans with a high proportion of African ancestry had lower baseline forced expiratory volume in one second (FEV1) per pack-year of smoking (−5.7 ml FEV1/ smoking pack-year) compared with smokers with lower African ancestry (−4.6 ml in FEV1/ smoking pack-year) (interaction P value = 0.17). Longitudinal analyses revealed a suggestive interaction between smoking, and African ancestry on the rate of FEV1 decline in Health ABC and independently replicated in CARDIA.
Citation: Aldrich MC, Kumar R, Colangelo LA, Williams LK, Sen S, Kritchevsky SB, et al. (2012) Genetic Ancestry-Smoking Interactions and Lung Function in African Americans: A Cohort Study. PLoS ONE 7(6): e39541. doi:10.1371/journal.pone.0039541
Editor: Olga Y. Gorlova, The University of Texas M. D. Anderson Cancer Center, United States of America
Received: January 27, 2012; Accepted: May 22, 2012; Published: June 21, 2012
Copyright: © 2012 Aldrich et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by the National Institutes of Health (HL078885, AI077439, HL088133, R01 HL74104, AI079139, AI061774, HL079055, DK064695, K23HL093023, HL092601, contracts N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, N01-HC-48047 through 48050, and N01-HC-95095), the Vanderbilt Clinical and Translational Research Scholars Program, the Flight Attendant Medical Research Institute (FAMRI), the American Asthma Foundation and the Sandler Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The NIA had final responsibility for the decision to submit for publication for Health ABC. The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham, University of Minnesota, Northwestern University, and Kaiser Foundation Research Institute. This manuscript has been reviewed by CARDIA for scientific content and consistency of data interpretation with previous CARDIA publications.
Competing interests: The authors have read the journal's policy and have the following conflicts: Dr. Aldrich has served as a Guest Editor for PLoS ONE. Christopher R. Gignoux holds stock with 23andMe, Inc. Dr. Smith received consultancy funds from Karmel-Sonix. Dr. Williams has received funding from Merck & Co for speaking engagements and travel. No other disclosures were reported. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Tobacco smoking is the leading cause of preventable deaths in the United States and is an important contributor to accelerated lung function decline . While European American individuals tend to smoke greater numbers of cigarettes when compared with African American individuals , , African Americans appear to have greater nicotine intake from tobacco smoke and lower renal clearance of cotinine . In addition, African Americans have lower normative lung function when compared with European Americans ,  and African ancestry is associated with lower pulmonary function . Despite these known disparities in smoking patterns, pharmacokinetics, and lung function, investigations of smoking-related diseases have been conducted primarily in European populations with relatively few studies devoted to other population groups. Therefore, the extent to which differences in exposure and susceptibility to tobacco smoke impact racial differences in lung function decline is unclear , . This question may have clinical or public health relevance since African American individuals may be particularly susceptible to smoking related diseases such as chronic obstructive lung disease , , , , .
Strong evidence from recent genome-wide association studies conducted in European American individuals implicates a genetic component to reduced lung function , , , , . Additionally, family-based studies, including a study conducted in adult African Americans , suggest that there is a strong heritable component to lung function . These heritability estimates increase among smokers , suggesting that the decline in lung function due to smoking is also genetically determined. Given the described differences by population, we hypothesized that the effect of tobacco smoking on lung function differs by genetic ancestry (i.e., a measure of one's African and European heritage). In the present study, we examined African Americans which have, on average, a mixed ancestry of approximately 80% African ancestry and 20% European ancestry . We investigated interactions between African genetic ancestry and tobacco smoking on forced expiratory volume in one second (FEV1) and its rate of decline in a large population of African Americans.
All participants gave written informed consent. The Institutional Review Boards at the University of Pittsburgh, the University of Tennessee and the University of California, San Francisco approved the Health ABC protocol. The CARDIA study is reviewed annually by the Institutional Review Boards at the University of Alabama Birmingham, Northwestern University Feinberg School of Medicine, University of Minnesota and Kaiser Permanente in Oakland. CARDIA participants sign a new informed consent form at every examination.
Health ABC Study Population
Self-identified European American (N = 1,794) and African American participants (N = 1,281) were enrolled into the ongoing prospective Health, Aging and Body Composition (Health ABC) cohort study between April 1997 and June 1998. Subjects were eligible for participation if they were Medicare recipients, aged 70–79 years, and resided near Pittsburgh, Pennsylvania or Memphis, Tennessee. Additional eligibility criteria for the Health ABC Study participants included speaking English, being free from a life-threatening illness, and willingness to remain in the study area for ≥3 years. Persons were excluded if they met any of the following criteria: a) difficulty with daily living activities, defined as any difficulty walking a quarter of a mile or any difficulty walking up 10 steps without resting; b) cognitive impairment; c) inability to communicate with an interviewer; or d) treated for cancer within the previous three years. Further details of the Health ABC study population have been published elsewhere , .
Interview Data Collection and Pulmonary Function Assessment
Demographic data and detailed smoking histories were collected from Health ABC participants using a structured questionnaire during an extensive home interview conducted within year one of study enrollment. Smaller versions of the questionnaire were implemented during subsequent years of the study. Individuals who reported smoking <100 cigarettes were categorized as never smokers and individuals who reported smoking at least 100 cigarettes during their lifetime (i.e. five or more packs) were queried about smoking initiation, cessation and average cigarettes per day. Using this information we categorized participants as current smokers and former smokers and estimated the number of smoking pack-years (i.e., [no. cigarettes smoked per day*no. of years smoked]/20).
Methods employed for assessment of pulmonary function in Health ABC study participants are described elsewhere in greater detail . Briefly, three to five spirometry tracings were obtained from enrolled participants during years 1, 5, 8 and 10 of the study period. All spirometry results were reviewed and scored for acceptability and reproducibility by two study staff. Pulmonary function tests meeting American Thoracic Society (ATS) criteria for acceptability and reproducibility were included in statistical analyses. This analysis includes participants who self-identified as African American and whose pulmonary function testing met the ATS standards.
Genotyping and Estimation of Genetic Admixture in Health ABC
Health ABC participants provided a blood sample from which genomic DNA was extracted and whole genome amplified. A panel of 1,536 autosomal biallelic ancestry informative markers was selected for genotyping in Health ABC African Americans. Markers were selected to distinguish the continental ancestral populations comprising African Americans , . The ancestry informative marker (AIM) panel was developed by selecting SNPs across the genome with high informativeness for ancestry between European and African continental populations. Genetic ancestry informative markers for West African and European ancestry were genotyped using Illumina technology. Methods for genotyping of SNPs informative for genetic ancestry, including the quality checks applied, have been previously described , . AIMs genotyping data were also available from West African (N = 104) and European (N = 241) ancestral populations for improvement of individual admixture estimation. For estimation of individual ancestry we included only AIMs found to be in Hardy Weinberg Equilibrium (HWE) and in linkage equilibrium among the West African and European ancestral populations . Genetic ancestry of the African American participants was determined using a final set of 1,332 AIMs and the software program STRUCTURE  to estimate the proportion of African and European ancestry in the Health ABC African Americans, assuming two ancestral populations.
Independent Replication of Longitudinal Analyses Coronary Artery Disease in Young Adults (CARDIA) Study
The CARDIA Study is a prospective cohort initiated in 1985, with 5,115 participants enrolled between the ages of 18 to 30 years from four clinical sites. Of these, 2,637 self-identified as African American. Detailed study design, recruitment procedures, and baseline findings have been previously reported , . Written informed consent was obtained for all subjects and IRB approval was obtained from each participating institution. For this analysis we included all non-asthmatic African American subjects with AIMs genotyping data available (N = 1,223). Spirometry was measured during years 0, 2, 5, 10, and 20 in accordance with ATS criteria for accuracy and precision . Subject's data was only included after age 25 to allow for lung function decline estimation starting from an age at which plateau lung function is typically attained. Smoking status was determined by standardized questionnaire at each visit and individuals were classified as never, former, or current smokers. Individual African ancestry in the African American study participants was determined using an independent panel of 42 biallelic autosomal markers having large allele frequency differences (delta >0.3) between African and European populations . As demonstrated by other investigators, this number of AIMs is sufficient for estimating ancestry among African Americans . The software program STRUCTURE  was used to estimate individual admixture proportions using a K = 2 estimate for the number of ancestral subpopulations.
Linear regression models were used to estimate the effect of African ancestry, coded as a continuous variable, on the association between tobacco smoke exposure and baseline FEV1 among African Americans without a self-reported diagnosis of pulmonary disease. Selection of covariates included in regression models was done using a priori knowledge of variables impacting pulmonary function resulting in the selection of age, sex, height, family income, and clinic site as covariates. Continuous variables were mean centered using measures collected at the time of study enrollment. Baseline analyses removed observations with standardized residuals greater than 2.5 (N = 5, indicating few statistical outliers). Two-way interaction terms between percent African ancestry and smoking pack-years were included in full linear regression models to estimate p-values for interactions. Linear regression models were also stratified by median African ancestry (80.8%) or smoking status (ever versus never) to assess interactions.
Linear mixed effects models examined the influence of African ancestry on tobacco smoke exposure and FEV1 decline, adjusting for the same covariates as in baseline analyses. Restricted maximum likelihood estimation was implemented to examine the impact of African ancestry on the association between tobacco smoke exposure and FEV1 decline while simultaneously accounting for the correlation structure between repeated pulmonary measures over the 10-year follow-up period in Health ABC. Smoking status was allowed to vary over time and continuous measures were mean centered. Similar linear mixed effects models were evaluated in CARDIA examining the relationship between African ancestry and smoking status (never, current, and former) on rate of pulmonary function decline. Covariates included sex, clinic, height, height-squared, body mass index (BMI), smoking pack-years and maximum attained education. Three-way interaction terms between age (as a measure of time), percent African ancestry, and smoking status were included in mixed models to estimate p-values for interactions. A two-sided significance probability of 0.05 was used to infer presence or absence of interaction. A p-value of 0.2 indicated suggestive evidence for the presence or absence of interaction, as a recommended strategy to reduce type II error and avoid missing a true interaction  and successfully implemented by others , . Analyses were performed using SAS, version 9.2 (Cary, North Carolina).
In its initial year, 1,281 African Americans, mean age 73.9 years, were enrolled in the Health ABC study. Repeat measures of pulmonary function were obtained during years one, five, eight and ten. At year one 942 African Americans had acceptable spirometry results and during years five, eight and ten there were 587, 406, and 337 individuals, respectively, had acceptable spirometry results; the remaining study individuals were either lost to follow-up or deceased over the ten year follow-up period (see Figure S1). Only 160 individuals (12%) reported having had a physician diagnosis of asthma, chronic obstructive pulmonary disease, chronic bronchitis, or emphysema at the initial visit and 77 (48%) of these 160 reported using pulmonary medications. The majority of African Americans in Health ABC had at least a high school education (56%) and 49% had a low income ($10,000–$25,000). Most African American participants were never smokers (45%), 39% were former smokers and 16% were current smokers. Mean smoking pack-years was 30 pack-years with an average of 12 cigarettes smoked per day (Table 1).
Baseline cross-sectional analyses
A total of 813 African Americans had both acceptable quality spirometry data and individual genetic ancestry estimates. Multivariable linear regression analyses demonstrated an inverse relationship between FEV1 and both African ancestry and amount smoked. Smoking was associated with a lower FEV1 among individuals with both high African ancestry (defined as greater than median value of 80.8%) and those with low African ancestry (less than or equal to 80.8%). The reduction in baseline FEV1 associated with smoking was greater among those with higher African ancestry. Table 2 illustrates that among smokers only African Americans with high African ancestry had lower baseline FEV1 per pack-year smoked (−5.7 ml FEV1/ smoking pack-year, 95% confidence interval [CI]: -8.1, -3.3) compared to individuals with low African ancestry (−4.6 ml in FEV1/ smoking pack-year, 95% CI: -7.5, -1.6). This difference was considered suggestive of an interaction between African ancestry and tobacco smoking pack-years exposure (P for interaction = 0.17) on baseline FEV1. Stratifying by smoking status (ever vs. never) also revealed a greater reduction in lung function with increasing African ancestry among smokers compared to never smokers (−4.4 ml in FEV1 versus −1.4 ml in FEV1), although the interaction between African ancestry and smoking status was not statistically significant (Table 3). We also examined FEV1/FVC and did not observe a significant interaction between African ancestry and smoking (data not shown).
Multivariable linear mixed effects models examining the rate of decline in FEV1 revealed a three-way interaction suggestive of a complex relationship between age, smoking, and individual African ancestry in the Health ABC study population, although results did not meet statistical significance (Table 4: Model 1 P = 0.14 for smoking pack-years; Model 2 P = 0.16 for former smokers). A sensitivity analysis removed individuals reporting pulmonary disease at baseline and found the effect was in the same direction although no longer statistically significant (P value >0.20). We applied a similar mixed effects model for FEV1 to the CARDIA study population (see Table S1). The numbers and ages of participants included at each visit are described in Table S2. We observed a suggestive interaction between age, former smoking status, and African ancestry (P = 0.12) among CARDIA participants (Table S3) even though this population was significantly younger than Health ABC participants. The longitudinal rate of decline in FEV1 in both Health ABC and CARDIA is illustrated in Figure 1 (Figure 1A: Health ABC, Figure 1B: CARDIA). While current smokers with high African ancestry had lower lung function than current smokers with low African ancestry, the rates of decline were similar between these two groups. Former smokers with high African ancestry also had lower lung function at baseline than former smokers with low African ancestry. However, in the case of former smokers, the rate of decline was less in individuals with high African ancestry. Among those who quit smoking, participants with higher African ancestry had a slower lung function decline, such that after follow-up, former smokers had similar lung function regardless of their proportion of African ancestry. These trends were observed in both Health ABC and CARDIA participants. We also examined FEV1/FVC in Health ABC and found a significant interaction between former smoking status, African ancestry and age (P = 0.02) and a suggestive interaction between smoking pack-years, African ancestry and age (P = 0.12).
Health ABC (A) and CARDIA (B). Current smokers are represented by the ▴ symbol and former smokers by the • symbol. Low African ancestry groups are represented by a solid line and high African ancestry by a dashed line. The groups are as follows: low African current smokers (solid line with ▴ symbol), high African current smokers (dashed line with ▴ symbol), low African former smokers (solid line with • symbol), and high African former smokers (dashed line with • symbol).
Using two independent adult cohorts, we demonstrated that smoking has a greater impact on reduced lung function among African Americans with high African ancestry than those with low African ancestry. Importantly, we found smokers with high African ancestry had lower baseline lung function than individuals with lower African ancestry. Inclusion of the 1,332 AIMs separately in models examining the association between tobacco smoke exposure and baseline FEV1 did not abrogate the response, even after correcting for multiple testing using false discovery rate , suggesting none of the ancestry informative markers were responsible for the observed associations. Moreover, baseline examination of FEV1 among European Americans indicated that their smoking-associated reduction in lung function was less (−3.9ml FEV1/ smoking pack-year) than in African Americans. It is well recognized that smoking leads to reduced lung function and increases the rate of lung function decline with increasing age . Despite this knowledge and established racial/ethnic differences for pulmonary function, few studies have examined the complex relationship between race, smoking, and rate of lung function decline among healthy adults. Using genetic ancestry, we can elucidate racial/ethnic differences in smoking-related lung function decline. Genetic ancestry itself is unlikely the cause of these differences, but may be a proxy for population-specific rare genetic variants contributing to racial/ethnic differences in lung function and susceptibility to tobacco smoke . Novel approaches, such as admixture mapping, may enable us to identify population-specific variants that contribute to lung function decline , .
Prior to our study, other groups have found inconsistent associations between race and smoking associated lung function decline. Vollmer et al. examined racial differences in smoking-related effects on cross-sectional FEV1 in European American and African American individuals and found no statistically significant difference in smoking associated decline . This is distinct from the findings of others who identified a greater susceptibility to FEV1 decline per pack-year smoked and a greater susceptibility to COPD among African American individuals , , . Some of the inconsistencies in prior investigations of racial differences in smoking-related pulmonary function may be due to their cross-sectional design  or designs which matched on smoking , thereby precluding the ability to examine its impact on racial differences in pulmonary measures. With statistical approaches only recently developed for estimating admixture, prior studies were unable to quantify the degree of African ancestry. Our study compliments and extends prior investigations comparing African American and European American individuals by examining smoking-related changes in lung function in relation to a continuous measure of African ancestry.
Our findings suggest that tobacco-related lung damage and African ancestry together have a substantially greater impact on lung function and perhaps its decline than either factor alone. In other words, the relationship between smoking and pulmonary function depends on the level of African ancestry. Individuals with high African ancestry are particularly susceptible to the impact of cigarette smoking on the decline of FEV1. In contrast to current smokers, former smokers with high African ancestry have lung function that becomes more similar to individuals with low African ancestry, suggesting lung function improves with smoking cessation irrespective of African ancestry. In fact, former smokers with high African ancestry may have an even greater benefit from smoking cessation, such that their lung function approaches that of former smokers with low African ancestry. These findings reveal greater complexity in the relationship between race and tobacco smoking associated lung function decline than was seen in an earlier study . Our findings suggest lung function depends on smoking status and the proportion of individual African ancestry and highlight the importance of smoking cessation. Future studies with greater statistical power are needed to confirm this relationship.
To assess potential survival bias, we compared baseline characteristics between those lost to follow-up and individuals remaining in the Health ABC study. Individuals remaining in the study were more likely to be male, higher BMI, higher education, fewer smoking pack-years, and lower African ancestry (Table S4) compared to those lost to follow up during the study period suggesting survival bias may impact our findings. However, we found similar associations in the younger CARDIA cohort with a 20-year follow-up and 65% retention for African American participants, thus supporting the robustness of our findings. CARDIA participants included in analyses were slightly more educated and included more females than participants not included in analyses, but were similar for other key demographic characteristics (Table S5). The consistency of the associations showing greater effect sizes in individuals of higher African ancestry for various measures of smoking suggests that smoking and African ancestry together may have an important impact on pulmonary function decline over time. We recognize that this observation may be due to social, environmental and genetic factors that co-vary with genetic ancestry. For example, environmental factors which could co-vary with ancestry include discrimination and proximity to roadways. The reduction in lung function in those with greatest African ancestry may have occurred in the distant past due to childhood or adolescent exposure to tobacco smoke leading to suboptimal lung growth or may be due to rapid decline in lung function in the early years of smoking.
Health ABC provides a robust approach for observing baseline spirometry measures, but also allows for assessment of longitudinal changes in lung function associated with smoking in this unique population of older African American adults. Replication of our findings in the CARDIA African American participants provides additional support. Few studies have ascertained repeated pulmonary function measures in either older populations or African American individuals. Thus the collection of repeated pulmonary function measures over a ten year time period in Health ABC and over 20 years in CARDIA is a notable strength of this study. Additionally, stringent protocols were implemented to ensure that quality spirometry measures were obtained. The prospective design of CARDIA and Health ABC minimizes possible participant response bias in reporting of smoking exposures.
In summary, we have demonstrated that African ancestry and tobacco use act synergistically to accelerate rate of lung function decline. Specifically, our results suggest that individuals with high African ancestry have increased risk of smoking-related changes in lung function and may be an important group for smoking intervention. In addition, the observation that former smokers with high African ancestry may have a less rapid rate of decline in lung function suggests that this group may preferentially benefit from cessation. Our findings have important public health implications. We have demonstrated that genetic ancestry may serve as a biomarker for identifying smokers who would benefit from targeted counseling regarding smoking cessation , . One important implication of our findings is that there may be rare genetic variants relevant to smoking associated lung function decline that are population-specific and which co-vary with genetic ancestry . While we cannot rule out that some of these associations may be in part due to environmental factors which co-vary with ancestry, these results highlight the scientific advantages of studying racially mixed populations. Future analyses should include admixture mapping to identify genomic regions associated with rate of lung function decline. These regions are likely to harbor rare population-specific variants that could illuminate pathogenetic pathways involved in the regulation of tobacco metabolism and lung function . Reduced lung function is a predictor of overall morbidity and mortality , ; therefore, it is imperative to recognize and intervene in the populations at greatest risk.
Flow chart of African Americans participating in the Health ABC Study.
Baseline demographic characteristics of 1,223 African Americans participating in the CARDIA study.
Number and mean ages of participants in the CARDIA study.
Longitudinal association between FEV1 decline, tobacco smoking and African ancestry, among African Americans participating in the CARDIA study.
Demographic characteristics of Health ABC African Americans lost to follow-up versus participants remaining in the study through year 10.
Demographic characteristics of non-asthmatic CARDIA African Americans who were included or not included in study sample due to lack of genetic data.
Conceived and designed the experiments: MCA RK SBK BM YL EGB. Performed the experiments: MCA SBK BM CRG YL TBH EZ JZ MG TSL MF KL LJS EGB. Analyzed the data: MCA RK LAC LKW SS KL JG DH CRG YL MG MGF EGB. Contributed reagents/materials/analysis tools: YL. Wrote the paper: MCA RK EGB. Critical revision of the manuscript for important intellectual content: MCA RK LAC LKW SS SBK BM JG DH CRG YL TBH EZ JZ MG TSL MGF LJS MF KL EGB. Final approval of the version to be published: MCA RK LAC LKW SS SBK BM JG DH CRG YL TBH EZ JZ MG TSL MGF LJS MF KL EGB.
- 1. Centers for Disease Control and Prevention (2008) Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000–2004. MMWR 57: 1226–1228.
- 2. Centers for Disease Control and Prevention (1998) Tobacco use among U.S. racial/ethnic minority groups–African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. A Report of the Surgeon General. Executive summary. MMWR Recomm Rep 47: v-xv, 1–16.
- 3. Trinidad DR, Perez-Stable EJ, Emery SL, White MM, Grana RA, et al. (2009) Intermittent and light daily smoking across racial/ethnic groups in the United States. Nicotine Tob Res 11: 203–210.
- 4. Perez-Stable EJ, Herrera B, Jacob P, 3rd, Benowitz NL (1998) Nicotine metabolism and intake in black and white smokers. JAMA 280: 152–156.
- 5. Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159: 179–187.
- 6. Harik-Khan RI, Muller DC, Wise RA (2004) Racial difference in lung function in African-American and White children: effect of anthropometric, socioeconomic, nutritional, and environmental factors. Am J Epidemiol 160: 893–900.
- 7. Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, et al. (2010) Genetic ancestry in lung-function predictions. N Engl J Med 363: 321–330.
- 8. Griffith KA, Sherrill DL, Siegel EM, Manolio TA, Bonekat HW, et al. (2001) Predictors of loss of lung function in the elderly: the Cardiovascular Health Study. Am J Respir Crit Care Med 163: 61–68.
- 9. Beaty TH, Menkes HA, Cohen BH, Newill CA (1984) Risk factors associated with longitudinal change in pulmonary function. Am Rev Respir Dis 129: 660–667.
- 10. Chatila WM, Wynkoop WA, Vance G, Criner GJ (2004) Smoking patterns in African Americans and whites with advanced COPD. Chest 125: 15–21.
- 11. Dransfield MT, Davis JJ, Gerald LB, Bailey WC (2006) Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med 100: 1110–1116.
- 12. Berry OF, Bhagat R, Ajelabi AA, Petrini MF (2008) Effect of smoking on spirometry of African American and White subjects. Chest 134: 1231–1236.
- 13. Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, et al. (2009) A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 5: e1000429.
- 14. Wilk JB, DeStefano AL, Arnett DK, Rich SS, Djousse L, et al. (2003) A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Respir Crit Care Med 167: 1528–1533.
- 15. Joost O, Wilk JB, Cupples LA, Harmon M, Shearman AM, et al. (2002) Genetic loci influencing lung function: a genome-wide scan in the Framingham Study. Am J Respir Crit Care Med 165: 795–799.
- 16. Redline S, Tishler PV, Lewitter FI, Tager IB, Munoz A, et al. (1987) Assessment of genetic and nongenetic influences on pulmonary function. A twin study. Am Rev Respir Dis 135: 217–222.
- 17. Gottlieb DJ, Wilk JB, Harmon M, Evans JC, Joost O, et al. (2001) Heritability of longitudinal change in lung function. The Framingham study. Am J Respir Crit Care Med 164: 1655–1659.
- 18. Whitfield KE, Wiggins SA, Belue R, Brandon DT (2004) Genetic and environmental influences on forced expiratory volume in African Americans: the Carolina African-American Twin Study of Aging. Ethn Dis 14: 206–211.
- 19. Rybicki BA, Beaty TH, Cohen BH (1990) Major genetic mechanisms in pulmonary function. J Clin Epidemiol 43: 667–675.
- 20. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, et al. (2009) The genetic structure and history of Africans and African Americans. Science 324: 1035–1044.
- 21. Waterer GW, Wan JY, Kritchevsky SB, Wunderink RG, Satterfield S, et al. (2001) Airflow limitation is underrecognized in well-functioning older people. J Am Geriatr Soc 49: 1032–1038.
- 22. Newman AB, Simonsick EM, Naydeck BL, Boudreau RM, Kritchevsky SB, et al. (2006) Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 295: 2018–2026.
- 23. Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, et al. (2005) A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 37: 1113–1118.
- 24. Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, et al. (2007) Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet 80: 716–726.
- 25. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945–959.
- 26. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, et al. (1988) CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41: 1105–1116.
- 27. Cutter GR, Burke GL, Dyer AR, Friedman GD, Hilner JE, et al. (1991) Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials 12: 1S–77S.
- 28. (1995) Respiratory diseases disproportionately affecting minorities. The NHLBI Working Group. Chest 108: 1380–1392.
- 29. Reiner AP, Carlson CS, Ziv E, Iribarren C, Jaquish CE, et al. (2007) Genetic ancestry, population sub-structure, and cardiovascular disease-related traits among African-American participants in the CARDIA Study. Hum Genet 121: 565–575.
- 30. Kosoy R, Nassir R, Tian C, White PA, Butler LM, et al. (2009) Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 30: 69–78.
- 31. Selvin S (1996) Statistical Analysis of Epidemiologic Data. New York: Oxford University Press.
- 32. Kwan ML, Block G, Selvin S, Month S, Buffler PA (2004) Food consumption by children and the risk of childhood acute leukemia. American journal of epidemiology 160: 1098–1107.
- 33. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, et al. (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. The New England Journal of Medicine 362: 800–811.
- 34. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 57: 289–300.
- 35. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, et al. (2005) Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 171: 109–114.
- 36. Gravel S, Henn BM, Gutenkunst RN, Indap AR, Marth GT, et al. (2011) Demographic history and rare allele sharing among human populations. Proc Natl Acad Sci.
- 37. Winkler CA, Nelson GW, Smith MW (2010) Admixture mapping comes of age. Annual Review of Genomics and Human Genetics 11: 65–89.
- 38. Reich D, Nalls MA, Kao WH, Akylbekova EL, Tandon A, et al. (2009) Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet 5: e1000360.
- 39. Vollmer WM, Enright PL, Pedula KL, Speizer F, Kuller LH, et al. (2000) Race and gender differences in the effects of smoking on lung function. Chest 117: 764–772.
- 40. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, et al. (2011) Early-Onset COPD is Associated with Female Gender, Maternal Factors, and African American Race in the COPDGene Study. Am J Respir Crit Care Med.
- 41. Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, et al. (2011) Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 43: 237–241.
- 42. Chanock SJ (2011) A twist on admixture mapping. Nat Genet 43: 178–179.
- 43. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747–753.
- 44. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118: 656–664.
- 45. Young RP, Hopkins R, Eaton TE (2007) Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 30: 616–622.